HansBiomed Price To Earning vs. Revenue
| 042520 Stock | KRW 7,750 60.00 0.78% |
For HansBiomed profitability analysis, we use financial ratios and fundamental drivers that measure the ability of HansBiomed to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well HansBiomed utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between HansBiomed's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of HansBiomed over time as well as its relative position and ranking within its peers.
HansBiomed |
HansBiomed Revenue vs. Price To Earning Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining HansBiomed's current stock value. Our valuation model uses many indicators to compare HansBiomed value to that of its competitors to determine the firm's financial worth. HansBiomed is number one stock in price to earning category among its peers. It also is the top company in revenue category among its peers totaling about 1,937,018,706 of Revenue per Price To Earning. Comparative valuation analysis is a catch-all model that can be used if you cannot value HansBiomed by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for HansBiomed's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.HansBiomed Revenue vs. Price To Earning
Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investors monitor daily. Holding a low PE stock is less risky because when a company's profitability falls, it is likely that earnings will also go down as well. In other words, if you start from a lower position, your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.
HansBiomed |
| = | 38.44 X |
Generally speaking, the Price to Earnings ratio gives investors an idea of what the market is willing to pay for the company's current earnings.
Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
HansBiomed |
| = | 74.46 B |
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
HansBiomed Revenue vs Competition
HansBiomed is the top company in revenue category among its peers. Market size based on revenue of Health Care industry is presently estimated at about 811.85 Billion. HansBiomed holds roughly 74.46 Billion in revenue claiming about 9% of equities under Health Care industry.
HansBiomed Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in HansBiomed, profitability is also one of the essential criteria for including it into their portfolios because, without profit, HansBiomed will eventually generate negative long term returns. The profitability progress is the general direction of HansBiomed's change in net profit over the period of time. It can combine multiple indicators of HansBiomed, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
HansBiomed Corporation, together with its subsidiaries, engages in the research and development, production, and sale of medical materials for the procedure and the raw materials for medical supplies. HansBiomed Corporation was founded in 1993 and is based in Seoul, South Korea. HANS BIOMED is traded on Korean Securities Dealers Automated Quotations in South Korea.
HansBiomed Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on HansBiomed. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of HansBiomed position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the HansBiomed's important profitability drivers and their relationship over time.
Use HansBiomed in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if HansBiomed position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in HansBiomed will appreciate offsetting losses from the drop in the long position's value.HansBiomed Pair Trading
HansBiomed Pair Trading Analysis
The ability to find closely correlated positions to HansBiomed could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace HansBiomed when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back HansBiomed - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling HansBiomed to buy it.
The correlation of HansBiomed is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as HansBiomed moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if HansBiomed moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for HansBiomed can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your HansBiomed position
In addition to having HansBiomed in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run SPAC Thematic Idea Now
SPAC
Entities that are involved in raising capital, merging with and acquiring companies, and investing in private equity through leveraged buyouts. The SPAC theme has 25 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize SPAC Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in HansBiomed Stock
To fully project HansBiomed's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of HansBiomed at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include HansBiomed's income statement, its balance sheet, and the statement of cash flows.